Lucy Scientific Discovery Inc (LSDI)
0.806
-0.08
(-9.46%)
USD |
NASDAQ |
May 02, 16:00
0.806
0.00 (0.00%)
After-Hours: 16:08
Lucy Scientific Discovery Enterprise Value: 2.496M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | 2.496M |
April 30, 2024 | 2.393M |
April 29, 2024 | 2.293M |
April 26, 2024 | 2.266M |
April 25, 2024 | 2.460M |
April 24, 2024 | 2.510M |
April 23, 2024 | 2.778M |
April 22, 2024 | 2.919M |
April 19, 2024 | 2.902M |
April 18, 2024 | 3.069M |
April 17, 2024 | 2.813M |
April 16, 2024 | 2.866M |
April 15, 2024 | 2.937M |
April 12, 2024 | 3.113M |
April 11, 2024 | 3.228M |
April 10, 2024 | 3.096M |
April 09, 2024 | 3.078M |
April 08, 2024 | 3.184M |
April 05, 2024 | 3.184M |
April 04, 2024 | 3.184M |
April 03, 2024 | 3.254M |
April 02, 2024 | 3.043M |
April 01, 2024 | 3.291M |
March 28, 2024 | 3.382M |
March 27, 2024 | 3.272M |
Date | Value |
---|---|
March 26, 2024 | 3.237M |
March 25, 2024 | 3.325M |
March 22, 2024 | 3.360M |
March 21, 2024 | 3.343M |
March 20, 2024 | 3.219M |
March 19, 2024 | 3.184M |
March 18, 2024 | 3.325M |
March 15, 2024 | 3.254M |
March 14, 2024 | 3.863M |
March 13, 2024 | 3.696M |
March 12, 2024 | 3.943M |
March 11, 2024 | 4.013M |
March 08, 2024 | 3.943M |
March 07, 2024 | 4.207M |
March 06, 2024 | 3.960M |
March 05, 2024 | 4.084M |
March 04, 2024 | 4.066M |
March 01, 2024 | 4.137M |
February 29, 2024 | 3.943M |
February 28, 2024 | 4.102M |
February 27, 2024 | 4.507M |
February 26, 2024 | 4.648M |
February 23, 2024 | 5.158M |
February 22, 2024 | 5.684M |
February 21, 2024 | 5.083M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.266M
Minimum
Apr 26 2024
58.16M
Maximum
Feb 15 2023
11.97M
Average
8.732M
Median
Enterprise Value Benchmarks
Rimrock Gold Corp | -- |
InMed Pharmaceuticals Inc | -7.948M |
Venus Concept Inc | 74.36M |
Juva Life Inc | -- |
CEN Biotech Inc | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.620M |
Revenue (Quarterly) | 0.0097M |
Total Expenses (Quarterly) | 0.8722M |
EPS Diluted (Quarterly) | -1.484 |
Gross Profit Margin (Quarterly) | 60.06% |
Profit Margin (Quarterly) | -27.05K% |
Earnings Yield | -879.0% |